HomeCompareSHPMF vs CL

SHPMF vs CL: Dividend Comparison 2026

SHPMF yields 3.81% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHPMF wins by $1402.76M in total portfolio value
10 years
SHPMF
SHPMF
● Live price
3.81%
Share price
$1.46
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1402.80M
Annual income
$1,335,511,443.90
Full SHPMF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — SHPMF vs CL

📍 SHPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHPMFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHPMF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHPMF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHPMF
Annual income on $10K today (after 15% tax)
$324.09/yr
After 10yr DRIP, annual income (after tax)
$1,135,184,727.32/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, SHPMF beats the other by $1,135,180,135.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHPMF + CL for your $10,000?

SHPMF: 50%CL: 50%
100% CL50/50100% SHPMF
Portfolio after 10yr
$701.42M
Annual income
$667,758,422.93/yr
Blended yield
95.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

SHPMF
No analyst data
Altman Z
2.0
Piotroski
5/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHPMF buys
0
CL buys
0
No recent congressional trades found for SHPMF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHPMFCL
Forward yield3.81%2.43%
Annual dividend / share$0.06$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28.6%
Portfolio after 10y$1402.80M$40.8K
Annual income after 10y$1,335,511,443.90$5,401.96
Total dividends collected$1397.96M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: SHPMF vs CL ($10,000, DRIP)

YearSHPMF PortfolioSHPMF Income/yrCL PortfolioCL Income/yrGap
1← crossover$11,463$762.55$11,012$312.01+$451.00SHPMF
2$13,899$1,633.80$12,196$412.95+$1.7KSHPMF
3$18,575$3,702.87$13,599$549.66+$5.0KSHPMF
4$29,124$9,249.68$15,288$736.64+$13.8KSHPMF
5$58,272$27,108.94$17,353$995.28+$40.9KSHPMF
6$163,733$101,382.29$19,926$1,357.80+$143.8KSHPMF
7$707,653$532,457.85$23,194$1,873.82+$684.5KSHPMF
8$5,058,632$4,301,444.15$27,439$2,621.52+$5.03MSHPMF
9$62,887,016$57,474,279.06$33,088$3,727.38+$62.85MSHPMF
10$1,402,800,551$1,335,511,443.90$40,806$5,401.96+$1402.76MSHPMF

SHPMF vs CL: Complete Analysis 2026

SHPMFStock

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Full SHPMF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this SHPMF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHPMF vs SCHDSHPMF vs JEPISHPMF vs OSHPMF vs KOSHPMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.